抗てんかん薬の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Epilepsy Drugs Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Epilepsy: An overview

PART 05: Pipeline analysis

PART 06: Key buying criteria for anti-epileptic drugs

PART 07: Market landscape
• Market overview
• Five forces analysis

PART 08: Market segmentation by generation of drugs
• First-generation anti-epileptic drugs
• Second-generation anti-epileptic drugs
• Third-generation anti-epileptic drugs

PART 09: Market segmentation by spectrum of activity
• Narrow-spectrum anti-epileptic drugs
• Broad-spectrum anti-epileptic drugs

PART 10: Market segmentation by type of seizures
• Partial onset seizures
• Generalized seizures

PART 11: Geographical segmentation
• Global epilepsy drugs market by geography 2016-2020
• Epilepsy drugs market in Americas
• Epilepsy drugs market in US
• Epilepsy drugs market in EMEA
• Epilepsy drugs market in APAC
• Epilepsy drugs market in Japan
• Epilepsy drugs market in Australia
• Epilepsy drugs market in China
• Epilepsy drugs market in India

PART 12: Market drivers
• Tentative approval of late-stage pipeline molecules
• Special regulatory designations
• Development of novel therapeutics using innovative technologies

PART 13: Impact of drivers

PART 14: Market challenges
• Social stigma associated with epilepsy
• Growing use of seizure management devices is a threat to drug therapies
• Gradual decrease in incentives/investment by vendors for new drug development

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Development of devices and smartphone apps to detect seizures and track medications
• Reformulation of marketed drugs
• Increased uptake of new-generation drugs

PART 17: Vendor landscape
• Competitive scenario
• Key news

PART 18: Key vendor analysis
• Eisai
• GSK
• Pfizer
• UCB
• Other prominent vendors

PART 19: Appendix
• List of abbreviations

PART 20: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Pipeline portfolio: Epilepsy drugs
Exhibit 03: Percentage share of pipeline molecules for global epilepsy drugs market
Exhibit 04: Key buying criteria for anti-epileptic drugs
Exhibit 05: Global epilepsy drugs market snapshot: Developed and emerging markets 2015
Exhibit 06: Global epilepsy drugs market 2015-2020 ($ billions)
Exhibit 07: A few research studies targeting cause of epilepsy
Exhibit 08: Segmentation of marketed anti-epileptic drugs based on mechanism of action
Exhibit 09: Five forces analysis
Exhibit 10: Timeline of development of anti-epileptic drugs
Exhibit 11: Segmentation of global anti-epileptic drugs market based on generation of drugs 2015
Exhibit 12: Opportunity analysis of global epilepsy drugs market by generation of drugs
Exhibit 13: Segmentation of global epilepsy drugs market by the spectrum of activity of drugs 2015
Exhibit 14: Segmentation of global epilepsy drugs market based on type of seizures
Exhibit 15: Global epilepsy drugs market by geography 2015-2020
Exhibit 16: Global epilepsy drugs market by geography 2015 and 2020
Exhibit 17: Global epilepsy drugs market by geography 2015-2020 ($ billions)
Exhibit 18: Epilepsy drugs market in Americas 2015-2020 ($ billions)
Exhibit 19: Epilepsy drugs market in Americas by geography 2015
Exhibit 20: Comparison of US healthcare system: Before and after reforms
Exhibit 21: Epilepsy drugs market in US 2015-2020 ($ billions)
Exhibit 22: Epilepsy drugs market in EMEA by geography 2015
Exhibit 23: Epilepsy drugs market in EMEA 2015-2020 ($ billions)
Exhibit 24: Epilepsy drugs market in APAC 2015-2020 ($ billions)
Exhibit 25: Epilepsy drugs market in APAC by geography 2015
Exhibit 26: Epilepsy drugs market in Japan 2015-2020 ($ millions)
Exhibit 27: Epilepsy drugs market in Australia 2015-2020 ($ millions)
Exhibit 28: Epilepsy drugs market in China 2015-2020 ($ millions)
Exhibit 29: Epilepsy drugs market in India 2015-2020 ($ millions)
Exhibit 30: Impact of drivers
Exhibit 31: Impact of drivers and challenges
Exhibit 32: Position of key vendors in global epilepsy drugs market 2015
Exhibit 33: Geographical presence of key vendors
Exhibit 34: Company portfolio analysis in global epilepsy drugs market 2016-2020
Exhibit 35: Eisai: YoY revenue and growth rate of Fycompa (Americas and EMEA) 2013-2015 ($ millions)
Exhibit 36: Eisai: YoY revenue and growth rate of Zonegran (EMEA) 2013-2015 ($ millions)
Exhibit 37: Eisai: YoY revenue and growth rate of Banzel (Americas and EMEA) 2013-2015 ($ millions)
Exhibit 38: Eisai: YoY revenue and growth rate of Zebinix (EMEA) 2013-2015 ($ millions)
Exhibit 39: Eisai: Metrics analysis
Exhibit 40: GSK: YoY revenue and growth rate of Lamictal 2013-2015 ($ millions)
Exhibit 41: GSK: Metrics analysis
Exhibit 42: Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
Exhibit 43: Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
Exhibit 44: Pfizer: Metrics analysis
Exhibit 45: UCB: YoY revenue and growth rate of Keppra 2013-2015 ($ millions)
Exhibit 46: UCB: Geographical segmentation of Keppra by revenue 2015
Exhibit 47: UCB: YoY revenue and growth rate of Vimpat 2013-2015 ($ millions)
Exhibit 48: UCB: Geographical segmentation of Keppra by revenue 2015
Exhibit 49: UCB: Metrics analysis


【レポート販売概要】

■ タイトル:抗てんかん薬の世界市場2016-2020
■ 英文:Global Epilepsy Drugs Market 2016-2020
■ 発行日:2016年7月5日
■ 調査会社:Technavio
■ 商品コード:IRTNTR8891
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。